For example, simultaneously inhibiting an oncogenic lncRNA that promotes proliferation (e.g., HOTAIR (154)) and delivering a tumor-suppressive miRNA mimic that enhances apoptosis or immune recognition (e.g., miR-34a (Li et al., 2015)) might yield greater efficacy. The gene discussed is HOTAIR; the disease is neoplasm.